In conclusion, the important role of HIF-1α in the group of patients with the high risk of recurrence and the negative histologic subtype of the tumor suggests that the expression of this factor might be useful in the panel of accessory pathomorphological tests and could be helpful in establishing more accurate prognosis in endometrial cancer patients. Here, HIF1A is linked to endometrial cancer.